Evidence map›Paper›PMID 39606004›Full record

ReviewFrontiers in psychiatry2024

An historical overview of artificial intelligence for diagnosis of major depressive disorder.

Hao Liu, Hairong Wu, Zhongli Yang, Zhiyong Ren, Yijuan Dong, Guanghua Zhang, Ming D Li

Abstract readReview
In one paragraph

Review in Frontiers in psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hao Liu *State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Hairong Wu *State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Zhongli YangState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Zhiyong RenShanxi Province Mental Health Center, Taiyuan Psychiatric Hospital, Taiyuan, China.
Yijuan DongShanxi Tongchuang Technology Inc., Taiyuan, China.
Guanghua ZhangSchool of Big Data Intelligent Diagnosis and Treatment Industry, Taiyuan University, Taiyuan, China.
Ming D LiState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Artificial Intelligence (AI) technology holds immense potential in the realm of automated diagnosis for Major Depressive Disorder (MDD), yet it is not without potential shortcomings. This paper systematically reviews the research progresses of integrating AI technology with depression diagnosis and provides a comprehensive analysis of existing research findings. In this context, we observe that the knowledge-driven first-generation of depression diagnosis methods could only address deterministic issues in structured information, with the selection of depression-related features directly influencing identification outcomes. The data-driven second-generation of depression diagnosis methods achieved automatic learning of features but required substantial high-quality clinical data, and the results were often obtained solely from the black-box models which lack sufficient explainability. In an effort to overcome the limitations of the preceding approaches, the third-generation of depression diagnosis methods combined the strengths of knowledge-driven and data-driven approaches. Through the fusion of information, the diagnostic accuracy is greatly enhanced, but the interpretability remains relatively weak. In order to enhance interpretability and introduce diagnostic criteria, this paper offers a new approach using Large Language Models (LLMs) as AI agents for assisting the depression diagnosis. Finally, we also discuss the potential advantages and challenges associated with this approach. This newly proposed innovative approach has the potential to offer new perspectives and solutions in the diagnosis of depression.

Indexed as

AI agentartificial intelligencelarge language modelmajor depressive disorderMDDmultimodal diagnosis

Identifiers

PMID39606004
PMCPMC11600139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.